Jacobs Levy Equity Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.5M | Buy |
984,742
+129,254
| +15% | +$3.09M | 0.09% | 195 |
|
|
2025
Q1 | $21.3M | Buy |
855,488
+401,227
| +88% | +$9.97M | 0.08% | 217 |
|
|
2024
Q4 | $8.56M | Buy |
+454,261
| New | +$8.56M | 0.03% | 327 |
|
|
2021
Q1 | – | Sell |
-55,041
| Closed | -$3.29M | – | 1098 |
|
|
2020
Q4 | $3.29M | Sell |
55,041
-4,723
| -8% | -$283K | 0.03% | 476 |
|
|
2020
Q3 | $3.59M | Sell |
59,764
-162,531
| -73% | -$9.77M | 0.04% | 415 |
|
|
2020
Q2 | $11.7M | Sell |
222,295
-20,882
| -9% | -$1.1M | 0.13% | 189 |
|
|
2020
Q1 | $8.15M | Buy |
243,177
+418
| +0.2% | +$14K | 0.1% | 209 |
|
|
2019
Q4 | $11M | Buy |
242,759
+46,660
| +24% | +$2.11M | 0.11% | 225 |
|
|
2019
Q3 | $7.47M | Buy |
196,099
+12,000
| +7% | +$457K | 0.09% | 263 |
|
|
2019
Q2 | $8.01M | Buy |
184,099
+13,660
| +8% | +$594K | 0.11% | 244 |
|
|
2019
Q1 | $6.49M | Buy |
170,439
+71,150
| +72% | +$2.71M | 0.09% | 282 |
|
|
2018
Q4 | $4.27M | Buy |
+99,289
| New | +$4.27M | 0.08% | 297 |
|
|
2017
Q4 | – | Sell |
-7,280
| Closed | -$273K | – | 1046 |
|
|
2017
Q3 | $273K | Buy |
+7,280
| New | +$273K | 0.01% | 806 |
|